At the tissue level, TCGA and Oncomine databases showed that FOXQ1 was upregulated in colon adenocarcinoma, lung adenocarcinoma, lung squamous cell carcinoma, thyroid carcinoma, and liver hepatocellular carcinoma and downregulated in kidney cancer and prostate adenocarcinoma. Here, FOXQ1 is linked to thyroid gland carcinoma.